Warning letters raise patient safety concerns for Fentora
October 22nd 2007In response to a number of deaths and serious adverse events reported by patients taking Fentora, warning letters were sent to health care professionals. According to Cephalon, Inc., the deaths primarily occurred as a result of improper patient selection, improper dosing, and/or improper product substitution.